Global Pharmaceutical Glass Packaging Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts

2022-06-10 18:54:33 By : Admin

CVC has sought to profit from the IPL’s rapid rise, large audience and valuable media rights deals

Global Pharmaceutical Glass Packaging Market

Dublin, June 08, 2022 (GLOBE NEWSWIRE) -- The "Pharmaceutical Glass Packaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The global pharmaceutical glass packaging market reached a value of US$ 8.05 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 12.63 Billion by 2027 exhibiting a CAGR of 7.40% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor. Glass is widely utilized as a packaging material for various pharmaceutical products. Some commonly used pharmaceutical glass packaging solutions include ultra-resistant borosilicate glass, surface treated soda-lime glass, regular soda-lime glass, and general-purpose soda-lime glass. It restricts atmospheric gases, such as carbon dioxide and oxygen, from entering the primary container, thus eliminating the risk of contamination of the medicines.

It also helps extend the shelf life of pharmaceutical products and prevents the escape of volatile ingredients, thereby increasing drug stability. Moreover, colored glass, such as amber and red-colored glass, can protect the contents from ultraviolet (UV) rays and specific wavelengths. In recent years, pharmaceutical glass packaging has rapidly gained traction due to its excellent strength, durability, transparency, recyclability, and chemical resistance. Global Pharmaceutical Glass Packaging Market Trends:

Pharmaceutical glass packaging protects the contents against physical damage, prevents biological contamination, and reduces the drug's susceptibility to degradation, such as hydrolysis and oxidation. As a result, the expanding pharmaceutical industry represents the primary factor driving the market growth.

Additionally, the growing need to extend the shelf life of medicinal products and the rising consumption of generic drugs and injectables are augmenting the product demand. Besides this, the widespread prevalence of chronic diseases like diabetes, increasing healthcare awareness among the masses, and elevating income levels are catalyzing the market growth.

Furthermore, governments of various countries are taking several favorable initiatives to encourage the usage of recycled glass to reduce the carbon footprint and ensure a safer and greener environment. Along with this, the launch of thin and lightweight glass bottles by leading manufacturers to minimize the overall consumption of energy and raw materials is propelling the market growth.

Other factors, including the emerging applications of glass bottles, improving healthcare infrastructure, rising environmental concerns, ongoing research and development (R&D) activities, and technological advancements, are also providing a positive thrust to the market growth. Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global pharmaceutical glass packaging market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, drug type and application. Breakup by Product:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Ardagh Group S.A, Beatson Clark, Bormioli Pharma S.p.A., Corning Incorporated, Gerresheimer AG, Nipro Corporation, Piramal Enterprises Ltd., Schott AG, SGD Pharma, Shandong Pharmaceutical Glass Co. Ltd., Sisecam (Turkiye Is Bankasi A.S.), Stolzle-Oberglas GmBH and West Pharmaceutical Services Inc. Key Questions Answered in This Report:

How has the global pharmaceutical glass packaging market performed so far and how will it perform in the coming years?

What has been the impact of COVID-19 on the global pharmaceutical glass packaging market?

What are the key regional markets?

What is the breakup of the market based on the product?

What is the breakup of the market based on the drug type?

What is the breakup of the market based on the application?

What are the various stages in the value chain of the industry?

What are the key driving factors and challenges in the industry?

What is the structure of the global pharmaceutical glass packaging market and who are the key players?

What is the degree of competition in the industry?

Key Topics Covered: 1 Preface 2 Scope and Methodology

3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Pharmaceutical Glass Packaging Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product 6.1 Bottles 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Vials 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Ampoules 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Cartridges and Syringes 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 Others 6.5.1 Market Trends 6.5.2 Market Forecast 7 Market Breakup by Drug Type 7.1 Generic 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Branded 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Biologic 7.3.1 Market Trends 7.3.2 Market Forecast 8 Market Breakup by Application 8.1 Oral 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Injectable 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Nasal 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Others 8.4.1 Market Trends 8.4.2 Market Forecast 9 Market Breakup by Region 10 SWOT Analysis 11 Value Chain Analysis 12 Porters Five Forces Analysis 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 Ardagh Group S.A 14.3.1.1 Company Overview 14.3.1.2 Product Portfolio 14.3.2 Beatson Clark 14.3.2.1 Company Overview 14.3.2.2 Product Portfolio 14.3.3 Bormioli Pharma S.p.A. 14.3.3.1 Company Overview 14.3.3.2 Product Portfolio 14.3.4 Corning Incorporated 14.3.4.1 Company Overview 14.3.4.2 Product Portfolio 14.3.4.3 Financials 14.3.4.4 SWOT Analysis 14.3.5 Gerresheimer AG 14.3.5.1 Company Overview 14.3.5.2 Product Portfolio 14.3.5.3 Financials 14.3.6 Nipro Corporation 14.3.6.1 Company Overview 14.3.6.2 Product Portfolio 14.3.6.3 Financials 14.3.6.4 SWOT Analysis 14.3.7 Piramal Enterprises Ltd. 14.3.7.1 Company Overview 14.3.7.2 Product Portfolio 14.3.7.3 Financials 14.3.8 Schott AG 14.3.8.1 Company Overview 14.3.8.2 Product Portfolio 14.3.8.3 SWOT Analysis 14.3.9 SGD Pharma 14.3.9.1 Company Overview 14.3.9.2 Product Portfolio 14.3.10 Shandong Pharmaceutical Glass Co. Ltd. 14.3.10.1 Company Overview 14.3.10.2 Product Portfolio 14.3.10.3 Financials 14.3.11 ?i?ecam (Turkiye ?? Bankas? A.?.) 14.3.11.1 Company Overview 14.3.11.2 Product Portfolio 14.3.11.3 Financials 14.3.12 Stolzle-Oberglas GmBH 14.3.12.1 Company Overview 14.3.12.2 Product Portfolio 14.3.13 West Pharmaceutical Services Inc. 14.3.13.1 Company Overview 14.3.13.2 Product Portfolio 14.3.13.3 Financials 14.3.13.4 SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/oo72aq

Global Pharmaceutical Glass Packaging Market

The average annual electricity cost of a popular small EV such as a Nissan Leaf or Renault Zoe is around £250.

Starting salaries accelerated at a near record pace last month, KPMG and the REC found.

The Global Refrigeration Lubricants Market is estimated to be valued at USD 3,285. 76 million in 2021. It is expected to reach USD 3,935. 51 million by 2027, registering a CAGR of 3. 67% from 2022 to 2027.New York, June 09, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Refrigeration Lubricants Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)" - https://www.reportlinker.com/p06249236/?utm_source=GNW Refrigiration lubricants have seen a surge i

There has been a large increase in nurse recruitment from ‘red list’ countries, says report.

As Chinese authorities signal that a two-year crackdown on the domestic technology sector is over, global investors are relieved and yet loath to take the government at its word. Foreign investors have been returning to mainland markets since May as its stringent COVID-19 lockdowns ease and after pledges from China's highest policymakers, including Vice Premier Liu He, to support an economy staring at recession. More explicit signs that the regulatory crackdown that crippled the technology sector is easing came this week with reports ride-hailing firm Didi Global and billionaire Jack Ma's Ant Group, the fintech affiliate of conglomerate Alibaba, are getting out of the regulatory doghouse.

The offer of financial compensation and medical insurance until the end of 2022 was available to the around 200 people working at the Nizhny Novgorod plant, a Volkswagen spokesperson said, confirming an earlier report by Kommersant paper. Volkswagen announced in March that production at its Kaluga and Nizhny Novgorod sites would be suspended until further notice because of Western sanctions, and vehicle exports to Russia would be stopped with immediate effect.

Major players in the market are Compass Group, Chobani, World Central Kitchen, Eden Creamery, AeroFarms, Safe Catch Foods, Union Wine Co. , Daily Harvest, a2 Milk, Amy’s Kitchen. The global specialty foods market is expected to grow from $158.New York, June 09, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Specialty Foods Global Market Report 2022" - https://www.reportlinker.com/p06284457/?utm_source=GNW 87 billion in 2021 to $170.21 billion in 2022 at a compound

OSB GROUP PLC ISIN: GB00BLDRH36010 June 2022 LEI: 213800ZBKL9BHSL2K459 OSB GROUP PLC (the Company) Transaction in Own Shares The Company announces that on 9 June 2022 it had purchased a total of 75,000 of its ordinary shares of £0.01 each on the London Stock Exchange through the Company's broker Citigroup Global Markets Limited as detailed below. The repurchased ordinary shares will be cancelled. London Stock ExchangeNumber of ordinary shares purchased75,000Highest price paid (per ordinary share

Higher energy bills, more costly food shops and soaring petrol pump prices have left families facing the biggest cost of living crisis in a generation. But it does not all have to be negative.

RAC calls it ‘dark day for drivers’ as latest increase puts cost of filling typical 55-litre family car at £100.27

The European Commission has proposed a deal to EU member states with Egypt and Israel to boost imports of natural gas from the eastern Mediterranean, according to a draft document seen by Reuters dated June 7. The draft memorandum of understanding, which is still subject to changes and needs approval from the governments involved, is part of European Union efforts to reduce fossil fuel imports from Russia following the war in Ukraine. "The natural gas to be shipped to the European Union will originate either from the Arab Republic of Egypt, the State of Israel, or any other source in the East Mediterranean region, including EU Member States in the region," the nine page document said.

ROME (Reuters) -Italian industrial output was much stronger than expected in April, rising 1.6% from the month before after a 0.2% gain in March, data showed on Friday, boosting growth prospects for the second quarter. April's jump in industry production confounded expectations for a drop of 1.1% in a Reuters survey of analysts, and marked the third consecutive monthly increase. National statistics bureau ISTAT revised up March's data from a previously reported flat reading.

Hydro's second quarter results 2022 will be released at 07:00 CET (01:00 EST, 06:00 UTC/GMT), on Friday, July 22, 2022. The quarterly report and presentation slides will be available on www.hydro.com at the same time. Executive Vice President and Chief Financial Officer Pål Kildemo will host an audio webcast and a conference call, in English, at 08:30 CET the same day. There will be no physical presentation or press conference. To listen to the presentation, please join the audio webcast. There

Research shows the economy was £31bn smaller than it would have been if it remained in the European Union.

With shares in BMO Commercial Property Trust (LON:BCPT) currently trading close to a 52 week high, a question many on the sidelines probably have is: quot;was...

Global Telecom Operations Management Market Global Telecom Operations Management Market Dublin, June 09, 2022 (GLOBE NEWSWIRE) -- The "Telecom Operations Management Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The global telecom operations management market reached a value of US$ 61.11 billion in 2021. Looking forward, the market is projected to reach a value of US$ 91.81 billion by 2027, exhi

Major players in the biosurfactants market are AGAE Technologies, Croda International plc, Evonik, GlycoSurf, Jeneil, Kemin Industries Inc. , Lion Corporation, TensioGreen, Biotensidon, Holiferm, Rhamnolipid, Saraya, Stepan Company, Victex, and Dispersa.New York, June 09, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Biosurfactants Global Market Report 2022" - https://www.reportlinker.com/p06284369/?utm_source=GNW The global biosurfactants market is expected to g

The vessel was designed and built in Belfast by maritime innovators Artemis Technologies.

LONDON (Reuters) -GSK aims to get its respiratory syncytial virus (RSV) vaccine to regulators for review later this year, after interim data showed the vaccine was effective in a keenly-watched late-stage study involving older adults. The latest GSK trial is the first to show statistically significant efficacy for RSV in adults aged 60 years and older, the British drugmaker said of the ongoing study on Friday. If approved, the RSV vaccine is expected to generate billions for GSK, which is already the world's biggest vaccine maker by sales but has faced pressure from activist investors such as Elliott Management who have urged the London-based company to shore up its drug pipeline.